News

A team of heart doctors at Henry Ford Hospital is the first in Michigan to perform a new catheter-based procedure which limits the risk of stroke in patients with atrial fibrillation who cannot take blood-thinning medications. More than...

Milestone Marks Next Step Toward FDA Submission for Stroke Reduction Device for Patients with Atrial Fibrillation Boston Scientific Corporation has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S. Food and Drug...

The Heart Rhythm Society (HRS), the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, has been named a Bronze winner in the “Health & Wellness” category of the 33rd Annual Telly...

CardioComm Solutions, Inc. has been contracted by the Heart and Stroke Foundation (HSF) as the preferred provider to run a electrocardiogram (ECG) screening program in Canada for the detection of cardiac arrhythmias with specific emphasis on...

Study evaluates sensitivity and positive predictive value of Sleep Apnea Monitoring (SAM) feature in implantable pacemakers Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced the...

World-renowned female electrophysiologists Professor Ellen Hoffmann and Professor Jeanne E. Poole are scheduled to chair the BIOTRONIK-supported EPIC Alliance (Electrophysiologist International Community) scientific session at the Cardiostim...

Unique Remapping Study Finds 86% of PVs Remained Electrically Isolated and Notes Physician Learning Curve of Only 10 Cases CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial...

RhythmView™ and FIRMap™ to be on display at Booth A36 Topera announced that its RhythmView™ 3D Electrophysiological Mapping System will be featured in 11 scientific presentations at Cardiostim 2012, the 18th WORLD CONGRESS on Cardiac EP...

Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced that its TactiCath Quartz force-sensing ablation catheter...

Capital to Fund Commercialization and Global Expansion of Breakthrough mHealth Devices AliveCor, the developer of a breakthrough mobile electrocardiogram (ECG) device, announced that it raised $10.5 million in Series B venture financing. The...